Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kratom Import Alert Clarifies FDA Deems The Botanical An Unsafe NDI

This article was originally published in The Tan Sheet

Executive Summary

FDA cautioned manufacturers about kratom’s safety as a dietary ingredient in 2013, but industry stakeholders posited that the agency should clarify whether the botanical is a legitimate supplement ingredient. The import alert and recall announcement should answer that question for manufacturers.


Related Content

FDA Turns Kratom's Future In US Dietary Supplement Market Into History
DEA Proposal To Schedule Kratom Stirs Wave Of Opposition
Kratom In Supplements Reaches Dead End On DEA Direct Regulatory Path
Kratom Action Presents Regulatory Puzzle For FDA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts